Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kopp, N.
Right arrow Articles by Leumann, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopp, N.
Right arrow Articles by Leumann, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1995) 10: 2224-2227
© 1995 European Renal Association-European Dialysis and Transplant Association


research-article

Changing pattern of primary hyperoxaluria in Switzerland

N. Kopp and E. Leumann

University Children's Hospital Zürich Switzerland

Correspondence and offprint requests to: Correspondence and offprint requests to: Prof. E. Leumann. University Children's Hospital, Steinwiesstr. 75, CH-8032 Zurich, Switzerland

BACKGROUND: The clinical course of primary hyperoxaluria (PH) is greatly variable and diagnosis is often delayed. Little is known about the overall occurrence and current prognosis.

METHODS: We evaluated all known patients with PH residing and observed in Switzerland during the last 15 years with the help of a survey among Swiss nephrologists.

RESULTS: Of the 25 patients observed between 7/79 and 6/94 in Switzerland, 18 were alive in 1994—14 on conservative therapy and four on renal replacement therapy (RRT). Twenty-two patients had PH type 1; the exact type was not determined in three. The estimated prevalence of PH (type 1) is 2 per million population; the minimal incidence is 1 per 100000 live births. Diagnosis was delayed by 8 years (median) except in infants. Five patients were pyridoxine sensitive. According to life table analysis, 20% of patients were in end-stage renal failure (ESRF) and 10% had died by the age of 15 years, and 50% were in ESRF and 20% dead at 25 years. Prognosis has improved: Five of 13 patients died during the first half of the observation period as opposed to two of 20 in the second part.

CONCLUSIONS: Overall prognosis appears better than hitherto believed considering the large clinical spectrum of PH. Greater awareness of PH is needed to improve further long-term prognosis.

Keywords: oxalosis; prevalence; primary hyperoxaluria; survey; Switzerland


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
C. S. van Woerden, J. W. Groothoff, R. J. A. Wanders, J.-C. Davin, and F. A. Wijburg
Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome
Nephrol. Dial. Transplant., February 1, 2003; 18(2): 273 - 279.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. LEUMANN and B. HOPPE
The Primary Hyperoxalurias
J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1986 - 1993.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.